We also investigated SNAI1 expression among dysplastic nevi and melanoma subgroups and revealed higher SNAI1 expression in BRAF+ and BRAF– melanoma samples than in dysplastic nevi and melanoma in situ. This evidence concerns the gene BRAF and in situ carcinoma.